‘UNMIXING’ Mixed-Type Intraductal Papillary Mucinous Neoplasms

View at publisher
Authors: Federico De Stefano, Peter Fagenholz, Jon M. Harrison, Yasmin G. Hernandez-Barco, Maria Imperatrice, Avinash Kambadakone, Mari Mino-Kenudson, Claudia Orlas-Bolanos, Motaz Qadan, Andrew Louis Warshaw, Keith D. Lillemoe, C Fern ndez-del Castillo
Cited by: 1

Abstract

OBJECTIVE: To determine the rate of malignancy in radiologically classified mixed-type intraductal papillary mucinous neoplasms (IPMNs) undergoing surgical resection compared to main-duct (MD) and branch-duct (BD) IPMNs. BACKGROUND: Mixed-IPMNs are widely perceived as high-risk lesions; however, limited and heterogeneous data available on this category raise uncertainty regarding their true risk profile. METHODS: Retrospective analysis of 836 consecutive resected IPMNs (2000-2025) from a prospectively maintained single-institution database. IPMNs were classified and compared based on preoperative imaging. Malignancy was defined as high-grade dysplasia or invasive carcinoma. RESULTS: Of 773 patients who met inclusion criteria, 305 (39.4%) had a radiologically defined mixed-IPMN, 135 (17.5%) MD-IPMN, and 333 (43.1%) BD-IPMN. Malignancy was observed in 46.5% of mixed-IPMNs (142/305), 79.2% MD-IPMNs (107/135), and 33.9% BD-IPMNs (113/333). The rate of invasive carcinoma was 19.0% (58/305) in mixed-IPMNs and 45.9% (62/135) in MD-IPMNs ( P

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Cholangiocarcinoma and Gallbladder Cancer Studies Gallbladder and Bile Duct Disorders

Publication details

Journal / source
Annals of Surgery
Publisher
Ovid Technologies (Wolters Kluwer Health)
Publication date
12 June 2026
Language
EN